Galena Biopharma Inc
Change company Symbol lookup
Select an option...
GALE Galena Biopharma Inc
ETE Energy Transfer Equity LP
EBIX Ebix Inc
FNMAK Federal National Mortgage Association
CLNY Colony Capital Inc
FUBAF Futaba Corp
ALDW Alon USA Partners LP
ROX Castle Brands Inc
CBM Cambrex Corp
MCFUF Micro Focus International PLC

Health Care : Biotechnology | Small Cap BlendCompany profile

Galena Biopharma, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing targeted oncology therapeutics. Its development portfolio ranges from mid- to late-stage clinical assets, including immunotherapy program led by its lead product NeuVax (nelipepimut-S), which is in Phase III clinical trial and is a targeted cancer immunotherapy. GALE-301 is an immunogenic peptide and can stimulate cytotoxic T lymphocytes to recognize and destroy Folate Binding Protein-expressing cancer cells. GALE-401 is a controlled release formulation of anagrelide. Its commercial drugs include Abstral (fentanyl) Sublingual Tablets is a treatment option for inadequately controlled breakthrough cancer pain and Zuplenz (ondansetron) Oral Soluble Film is approved by the Food and Drug Administration in adult patients for the prevention of emetogenic chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea and vomiting, and post-operative nausea and vomiting.

Closing Price
Day's Change
0.02 (1.23%)
B/A Size
Day's High
Day's Low
10-day average volume:
  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    3:59p ET 10/02/15
  • Last (size)
  • 52-Wk Range
    1.10 - 2.39
  • (06/08/15 - 08/24/15)
  • 66.8%
  • Market Cap
  • Shares Outstanding
  • -0.29
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 0.4
  • 16.60
  • (% of float 09/15/15)

Latest News

September 30, 2015
7:05 am ET
Globe Newswire
September 29, 2015
9:12 am ET
PR Newswire
September 28, 2015
7:05 am ET
Globe Newswire
September 23, 2015
9:00 am ET
PR Newswire
September 14, 2015
7:05 am ET
Globe Newswire
September 01, 2015
7:05 am ET
Globe Newswire
August 31, 2015
11:00 am ET
PR Newswire
August 24, 2015
7:05 am ET
Globe Newswire
August 06, 2015
4:18 pm ET
Globe Newswire
August 05, 2015
10:03 am ET
Globe Newswire
July 29, 2015
7:05 am ET
Globe Newswire
July 28, 2015
7:05 am ET
Globe Newswire
July 17, 2015
9:25 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2015 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by SunGard.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by , Computrade Systems, Inc.,, , and

Copyright © 2015. All rights reserved.